Bio Solution Co.,Ltd.
Develops cell therapies, human tissue models, and bio-laboratory products.
086820 | KO
Overview
Corporate Details
- ISIN(s):
- KR7086820008
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 노원구 공릉로 232 5층 (공릉동, 서울테크노파크), 서울특별시
- Website:
- https://bio-solution.co.kr/
- Sector:
- Manufacturing
Description
Bio Solution Co., Ltd. is a biotechnology company focused on the development, manufacturing, and sale of cell therapy products. The company's core activities involve cell-based biotechnology, producing therapeutics such as autologous chondrocyte treatments for cartilage regeneration. In addition to its therapeutic offerings, Bio Solution develops human tissue models and provides alternative testing solutions. The company also manufactures and distributes a portfolio of bio-laboratory products, including ready-to-use kits, staining solutions, and various reagents for molecular biology research and development applications.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-08-23 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 105.8 KB | ||
| 2021-08-18 00:00 |
기타경영사항(특허권취득)(자율공시)(기능이 강화된 세포외 소포를 고농도로 함유하고 있는 조건화 배양액의 탈모 완화 및 방지 용도)
|
Korean | 6.8 KB | ||
| 2021-08-17 00:00 |
반기보고서 (2021.06)
|
Korean | 797.1 KB | ||
| 2021-08-13 00:00 |
증권발행결과(자율공시)(제1회 무기명식 이권부 무보증 사모 전환사채)
|
Korean | 7.0 KB | ||
| 2021-07-29 00:00 |
[기재정정]주요사항보고서(전환사채권발행결정)
|
Korean | 39.3 KB | ||
| 2021-07-28 00:00 |
[기재정정]주요사항보고서(전환사채권발행결정)
|
Korean | 53.1 KB | ||
| 2021-07-15 00:00 |
[기재정정]주요사항보고서(전환사채권발행결정)
|
Korean | 60.4 KB | ||
| 2021-06-14 00:00 |
기타경영사항(특허권취득)(자율공시)(물질 P 를 포함하는 주름 개선 또는 항염증 화장료 조성물(일본특허))
|
Korean | 5.2 KB | ||
| 2021-05-17 00:00 |
분기보고서 (2021.03)
|
Korean | 1.1 MB | ||
| 2021-05-04 00:00 |
기타경영사항(특허권취득)(자율공시)(락토페린과 결합하고 있는 고농도의 세포외 소포를 함유하는 조건화 배양액)
|
Korean | 5.8 KB | ||
| 2021-05-04 00:00 |
[기재정정]기타경영사항(특허권취득)(자율공시)(락토페린과 결합하고 있는 고농도의 세포외 소포를 함유하는 조건화 배양액)
|
Korean | 8.9 KB | ||
| 2021-04-16 00:00 |
주요사항보고서(전환사채권발행결정)
|
Korean | 33.6 KB | ||
| 2021-04-02 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 79.7 KB | ||
| 2021-03-29 00:00 |
정기주주총회결과
|
Korean | 21.6 KB | ||
| 2021-03-29 00:00 |
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 9.3 KB |
Automate Your Workflow. Get a real-time feed of all Bio Solution Co.,Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Bio Solution Co.,Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Bio Solution Co.,Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
